CONMED's first quarter was marked by strong revenue and non-GAAP profit performance, which exceeded Wall Street expectations and led to a significant positive market reaction. Management attributed ...

Good day, and thank you for standing by. Welcome to CONMED's First Quarter Fiscal 2025 Earnings Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded.

CEO Pat Beyer highlighted total Q1 sales of $321.3 million, marking a 2.9% year-over-year increase as reported and a 3.8% growth in constant currency. Adjusted net income increased 19.6% to $29.6 ...